CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation

  • Paulo Caleb Junior Lima Santos, Carla Luana Dinardo, Isolmar Tadeu Schettert, Renata Alonso Gadi Soares, Liz Kawabata-Yoshihara, Isabela Martins Bensenor, José Eduardo Krieger, Paulo Andrade Lotufo, Alexandre Costa Pereira
  • European Journal of Clinical Pharmacology, September 2012, Springer Science + Business Media
  • DOI: 10.1007/s00228-012-1404-5

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s00228-012-1404-5

The following have contributed to this page: Jose Krieger